Ask Michael Burke Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (64820)	7/19/1999 11:14:00 AM
From: Merritt	Read Replies (1) of 132070

Gary, he also believed in the technology of GLYC and GRPI and others that failed to make the grade. He's had some good ones too, but the point I'd like to get across is not to put too much faith in him, or anyone else. Especially with Biotech, it pays to diversify as there are just too many unknowns that can't be factored into valuations. No matter how knowledgeable one is about a company, you'll never know enough...even the "insiders" can't be certain of the company's future, or else we wouldn't have products fail in PIII, or not get FDA approval. As for IMGN, I haven't followed them for a while as I've formed the personal opinion that they were too touty as well as far from getting anything to market after all these years (perhaps too subjective of me, but it's saved me money in the past<g>)...are they still using a ricin-based drug...and how are the PI trials designed, e.g. are they using healthy volunteers?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next